Accession Title Organisms BioProject accession Organization Release time
SAMC784994 msday21control Mus musculus PRJCA004238 Zhongshan Ophthalmic Center,Sun Yat-sen University 2022-08-11
SAMC784993 msday14control Mus musculus PRJCA004238 Zhongshan Ophthalmic Center,Sun Yat-sen University 2022-08-11
SAMC784992 msday7control Mus musculus PRJCA004238 Zhongshan Ophthalmic Center,Sun Yat-sen University 2022-08-11
SAMC309199 mlym_Day21_2 Mus musculus PRJCA004238 Zhongshan Ophthalmic Center,Sun Yat-sen University 2022-08-11
SAMC309198 mlym_Day21_1 Mus musculus PRJCA004238 Zhongshan Ophthalmic Center,Sun Yat-sen University 2022-08-11
SAMC309197 mlym_Day14_2 Mus musculus PRJCA004238 Zhongshan Ophthalmic Center,Sun Yat-sen University 2022-08-11
SAMC309196 mlym_Day14_1 Mus musculus PRJCA004238 Zhongshan Ophthalmic Center,Sun Yat-sen University 2022-08-11
SAMC309195 mlym_Day7_2 Mus musculus PRJCA004238 Zhongshan Ophthalmic Center,Sun Yat-sen University 2022-08-11
SAMC309194 mlym_Day7_1 Mus musculus PRJCA004238 Zhongshan Ophthalmic Center,Sun Yat-sen University 2022-08-11
SAMC309193 mlym_Day0_2 Mus musculus PRJCA004238 Zhongshan Ophthalmic Center,Sun Yat-sen University 2022-08-11
SAMC309192 mlym_Day0_1 Mus musculus PRJCA004238 Zhongshan Ophthalmic Center,Sun Yat-sen University 2022-08-11
SAMC335210 Beagle_hippocampus Canis lupus familiaris PRJCA004294 Kunming Institute of Zoology, Chinese Academy of Sciences 2022-08-11
SAMC829350 RNA seq of mice Mus PRJCA010834 Third Military Medical University(Army Medical University) 2022-08-11
SAMC829349 RNA seq of mice Mus PRJCA010834 Third Military Medical University(Army Medical University) 2022-08-11
SAMC829348 RNA seq of mice Mus PRJCA010834 Third Military Medical University(Army Medical University) 2022-08-11
SAMC829347 RNA seq of mice Mus PRJCA010834 Third Military Medical University(Army Medical University) 2022-08-11
SAMC829346 RNA seq of mice Mus PRJCA010834 Third Military Medical University(Army Medical University) 2022-08-11
SAMC829345 RNA seq of mice Mus PRJCA010834 Third Military Medical University(Army Medical University) 2022-08-11
SAMC829344 RNA seq of mice Mus PRJCA010834 Third Military Medical University(Army Medical University) 2022-08-11
SAMC829343 RNA seq of mice Mus PRJCA010834 Third Military Medical University(Army Medical University) 2022-08-11


Accession Title Organisms Release Time
SAMN30223204 Sample from a human female participant in the dbGaP study "A Randomized Multi-Institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck" Homo sapiens 2022-08-10
SAMN30223203 Sample from a human male participant in the dbGaP study "A Randomized Multi-Institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck" Homo sapiens 2022-08-10
SAMN30223202 Sample from a human male participant in the dbGaP study "A Randomized Multi-Institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck" Homo sapiens 2022-08-10
SAMN30223201 Sample from a human male participant in the dbGaP study "A Randomized Multi-Institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck" Homo sapiens 2022-08-10
SAMN30223200 Sample from a human male participant in the dbGaP study "A Randomized Multi-Institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck" Homo sapiens 2022-08-10
SAMN30223199 Sample from a human male participant in the dbGaP study "A Randomized Multi-Institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck" Homo sapiens 2022-08-10
SAMN30223198 Sample from a human male participant in the dbGaP study "A Randomized Multi-Institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck" Homo sapiens 2022-08-10
SAMN30223197 Sample from a human male participant in the dbGaP study "A Randomized Multi-Institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck" Homo sapiens 2022-08-10
SAMN30223196 Sample from a human male participant in the dbGaP study "A Randomized Multi-Institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck" Homo sapiens 2022-08-10
SAMN30223195 Sample from a human male participant in the dbGaP study "A Randomized Multi-Institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck" Homo sapiens 2022-08-10
  • Total Items: 27963720
  • Items of 1 - 10
  • Page size 10  
  • Page 1/2796372 
  • << First    Next >